The results of an international clinical trial, led in part by a UC Davis School of Medicine expert, have shown that a drug therapy for a severe type of muscular dystrophy holds promise for a subgroup of patients. In a paper just published online in the journal The Lancet, Craig McDonald and colleagues at 53 study sites in...